Search This Blog

Monday, November 23, 2015

Amgen Announces Repatha® Preferred Position On CVS Health Commercial Formularies

The Nation's Two Largest Pharmacy Benefit Managers Now Provide Access to Innovative Cholesterol-Lowering Medication Repatha® (Evolocumab) For Millions of Patients in Need



Amgen - Investors - RSS Content

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.